U.S. Markets open in 15 hrs, 30 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,246.97 | 20.03 | 0.20% |
| NASDAQ | 2,151.08 | -2.98 | -0.14% |
| S&P 500 | 1,093.01 | -0.07 | -0.01% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
The investment seeks high total return.
The fund primarily invests in common stocks of non-U.S. issuers, including dividend-paying common stocks. It maintains investments in no fewer than three foreign countries. The relative emphasis on capital appreciation or income depends on the views of management. To determine geographic allocation, management evaluates the growth potential of different markets, currency and taxation considerations, and other pertinent social, financial, political, and national factors. The fund may also enter into various derivative transactions for hedging and risk-management purposes.
| Name | % of Total Fund Assets | |
|---|---|---|
| GlaxoSmithKline PLC (GLAXF) | 3.91 % | |
| Sanofi-Aventis (SAN) | 3.13 % | |
| Novartis () | 2.74 % | |
| S&P Index (Fut () | 2.67 % | |
| S&P Index (Fut () | 2.4 % | |
| View Holdings | ||
Foreign Large Value
Below Average
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Historical prices provided by Prophet. © [2007] Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.